药品批准更新。
Pharmaceutical Approval Update.
作者信息
Kaufman Michele B
出版信息
P T. 2018 Dec;43(12):734-735.
Abstract
Mulpleta (lusutrombopag) for thrombocytopenia; ajovy (fremenezumab-vfrm) for migraine; takhzyro (lanadelumab-flyo) for hereditary angioedema attacks.
摘要
用于治疗血小板减少症的Mulpleta（芦曲泊帕）；用于治疗偏头痛的Ajovy（fremanezumab-vfrm）；用于治疗遗传性血管性水肿发作的Takhzyro（lanadelumab-flyo）。
相似文献
1
Pharmaceutical Approval Update.药品批准更新。
P T. 2018 Dec;43(12):734-735.
2
Transition to lanadelumab-flyo from three medications for a hereditary angioedema patient with a variant in the gene: A case report.一名遗传性血管性水肿患者从三种药物转换为使用lanadelumab-flyo治疗，该患者的基因存在变异：病例报告。
Clin Case Rep. 2021 Mar 20;9(4):2438-2441. doi: 10.1002/ccr3.4060. eCollection 2021 Apr.
3
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial.拉那芦单抗对比安慰剂预防遗传性血管性水肿发作的效果：一项随机临床试验。
JAMA. 2018 Nov 27;320(20):2108-2121. doi: 10.1001/jama.2018.16773.
4
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension.一项评估拉那度单抗预防遗传性血管性水肿发作的长期安全性和有效性的开放标签研究：HELP研究扩展的设计。
Clin Transl Allergy. 2017 Oct 6;7:36. doi: 10.1186/s13601-017-0172-9. eCollection 2017.
5
Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis.抑制血浆激肽释放酶用于遗传性血管性水肿预防。
N Engl J Med. 2017 Feb 23;376(8):717-728. doi: 10.1056/NEJMoa1605767.
6
Lusutrombopag: First Global Approval.芦曲泊帕：全球首次获批。
Drugs. 2016 Jan;76(1):155-8. doi: 10.1007/s40265-015-0525-4.
7
Lusutrombopag (Mulpleta®) treatment in a patient with thrombocytopenia complicated by cirrhosis prior to continuous epidural anesthesia during renal artery embolization: a case report.卢索替尼（Mulpleta®）治疗肾动脉栓塞期间连续硬膜外麻醉前合并肝硬化的血小板减少症患者：一例报告
JA Clin Rep. 2018 Nov 20;4(1):80. doi: 10.1186/s40981-018-0217-7.
8
Lanadelumab for the prevention of attacks in hereditary angioedema.拉那芦单抗预防遗传性血管性水肿发作。
Expert Rev Clin Immunol. 2019 Dec;15(12):1239-1248. doi: 10.1080/1744666X.2020.1693261. Epub 2019 Nov 19.
9
Lanadelumab: A Review in Hereditary Angioedema.拉那芦单抗：遗传性血管性水肿治疗药物。
Drugs. 2019 Nov;79(16):1777-1784. doi: 10.1007/s40265-019-01206-w.
10
Lusutrombopag: A Review in Thrombocytopenia in Patients with Chronic Liver Disease Prior to a Scheduled Procedure.芦曲泊帕：计划手术前慢性肝病患者血小板减少症的治疗药物评价。
Drugs. 2019 Oct;79(15):1689-1695. doi: 10.1007/s40265-019-01197-8.
引用本文的文献
1
Knowledge map of thrombopoietin receptor agonists: A bibliometric analysis.血小板生成素受体激动剂的知识图谱：一项文献计量分析。
Heliyon. 2024 Jan 4;10(1):e24051. doi: 10.1016/j.heliyon.2024.e24051. eCollection 2024 Jan 15.
Zotero 插件